April 26, 2011
A meningitis vaccine already in use has been approved by the Food and Drug Administration for children as young as 9 months old.
The two-dose vaccine, Menactra, which produces antibodies against a strain of meningococcus bacteria, was approved in 2005 for 11- to 55-year-olds and in 2007 for 2-year-olds.
Though meningitis cases are relatively rare—about 1,000 to 2,600 cases per year—the disease can be deadly.
This article was posted: Tuesday, April 26, 2011 at 9:40 am